USPTO serial 87979442
MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 12, 2019
- Examiner
- DINALLO, KEVIN M
- Law office
- FILE DESTROYED
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation
Edison, NJ
Other trademarks owned by Musculoskeletal Transplant Foundation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William W. Stroever
William W. Stroever Cole Schotz P.C.25 Main StreetHackensack, NJ 07601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allograft material, namely, processed human bone and tissue for use in surgical or medical procedures; Allograft material, namely, human bone and tissue processed into implants, scaffolds, powders, gels, pastes, putty, mats, films, strips, sheets, molded pieces, surgical patches, plugs, wound dressings, or wound coverings; Growth factors, namely, proteins for promoting tissue growth and repair, processed into surgical implants, scaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Adipose cavity filler; Soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and bone | ACTIVE | — |
| 040 | Human allograft tissue processing services, namely, preparing biological tissue for subsequent implantation in the human body | ACTIVE | — |
| 044 | Human allograft tissue bank donor services; Maintaining files and records concerning the donation of human tissue between and among the hospital, donor and recipient; Medical services in the field of human tissue, cells, bone and organ donations, namely, obtaining donor consent and human donor referrals, conducting donor screening surveys, collecting donor medical data, coordinating donor recoveries with outside entities, and providing statistical donor data to others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks owned by Musculoskeletal Transplant Foundation
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 044
- Similar marks named MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 10, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 10, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 26, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Feb 12, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 12, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 9, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 8, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2019 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 27, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Dec 20, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 28, 2018 | IUAF | USE AMENDMENT FILED | — |
| Nov 28, 2018 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 28, 2018 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 28, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 20, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 18, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 18, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 3, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 3, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 24, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 24, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 18, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 18, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 5, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 5, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 5, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 5, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 1, 2017 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 1, 2017 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |